A Study of the Onset and Offset of Antiplatelet Effects Comparing Ticagrelor, Clopidogrel, and Placebo With Aspirin

PHASE2CompletedINTERVENTIONAL
Enrollment

123

Participants

Timeline

Start Date

October 31, 2007

Primary Completion Date

March 31, 2009

Study Completion Date

March 31, 2009

Conditions
Coronary Artery Disease
Interventions
DRUG

Ticagrelor Tablets

Oral, 90 mg; 180 mg loading dose followed by 90 mg twice daily (BD)

DRUG

Clopidogrel (over encapsulated) capsule

Oral 75 mg; 600 mg loading dose followed by 75 mg once daily (ODD)

DRUG

Aspirin Tablets

Oral, 75 mg to 100 mg once daily. Aspirin obtained locally by the investigator, according to local practice. The dose remained constant throughout the study.

Trial Locations (9)

Unknown

Research Site, Baton Rouge

Research Site, Baltimore

Research Site, Towson

Research Site, Cincinnati

Research Site, Oklahoma City

Research Site, Philadelphia

Research Site, Rapid City

Research Site, Houston

Research Site, Sheffield

Sponsors

Lead Sponsor

All Listed Sponsors
lead

AstraZeneca

INDUSTRY